Literature DB >> 28748522

Mindfulness-Based Interventions and Sleep Among Cancer Survivors: a Critical Analysis of Randomized Controlled Trials.

Georgia Christodoulou1, David S Black2,3.   

Abstract

PURPOSE OF REVIEW: The purpose of our critical examination is to present results and provide a synthesis of this body of work. RECENT
FINDINGS: Sleep problems among cancer survivors are gaining research attention. To our knowledge, there have been six randomized control trials published from 2013 to 2015 that test the effects of mindfulness-based interventions (MBIs) on sleep as a primary or secondary outcome. Our examination of the literature highlights important methodological issues and variability among trials. We conclude our review by offering solutions to facilitate more scientific rigor in future studies.

Entities:  

Keywords:  Cancer; Insomnia; Mindfulness; Sleep; Survivors

Mesh:

Year:  2017        PMID: 28748522      PMCID: PMC7426071          DOI: 10.1007/s11912-017-0621-6

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  29 in total

Review 1.  What is the evidence for the use of mindfulness-based interventions in cancer care? A review.

Authors:  Christina Shennan; Sheila Payne; Deborah Fenlon
Journal:  Psychooncology       Date:  2010-08-04       Impact factor: 3.894

2.  Validation of the Insomnia Severity Index in primary care.

Authors:  Christine Gagnon; Lynda Bélanger; Hans Ivers; Charles M Morin
Journal:  J Am Board Fam Med       Date:  2013 Nov-Dec       Impact factor: 2.657

3.  The course of psychological disorders in the 1st year after cancer diagnosis.

Authors:  Maria Kangas; Jane L Henry; Richard A Bryant
Journal:  J Consult Clin Psychol       Date:  2005-08

4.  Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism?

Authors:  Julienne E Bower; Patricia A Ganz; Michael R Irwin; Lorna Kwan; Elizabeth C Breen; Steve W Cole
Journal:  J Clin Oncol       Date:  2011-08-08       Impact factor: 44.544

5.  Mindfulness meditation for younger breast cancer survivors: a randomized controlled trial.

Authors:  Julienne E Bower; Alexandra D Crosswell; Annette L Stanton; Catherine M Crespi; Diana Winston; Jesusa Arevalo; Jeffrey Ma; Steve W Cole; Patricia A Ganz
Journal:  Cancer       Date:  2014-12-23       Impact factor: 6.860

6.  Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program.

Authors:  Oxana G Palesh; Joseph A Roscoe; Karen M Mustian; Thomas Roth; Josée Savard; Sonia Ancoli-Israel; Charles Heckler; Jason Q Purnell; Michelle C Janelsins; Gary R Morrow
Journal:  J Clin Oncol       Date:  2009-11-23       Impact factor: 44.544

7.  Mindfulness-based cognitive therapy improves polysomnographic and subjective sleep profiles in antidepressant users with sleep complaints.

Authors:  Willoughby B Britton; Patricia L Haynes; Keith W Fridel; Richard R Bootzin
Journal:  Psychother Psychosom       Date:  2012-07-20       Impact factor: 17.659

8.  Sleep disturbance in cancer patients.

Authors:  Judith R Davidson; Alistair W MacLean; Michael D Brundage; Karleen Schulze
Journal:  Soc Sci Med       Date:  2002-05       Impact factor: 4.634

Review 9.  The effect of mindfulness-based therapy on symptoms of anxiety and depression in adult cancer patients and survivors: a systematic review and meta-analysis.

Authors:  Jacob Piet; Hanne Würtzen; Robert Zachariae
Journal:  J Consult Clin Psychol       Date:  2012-05-07

10.  Quality of life in patients with breast cancer before and after diagnosis: an eighteen months follow-up study.

Authors:  Ali Montazeri; Mariam Vahdaninia; Iraj Harirchi; Mandana Ebrahimi; Fatemeh Khaleghi; Soghra Jarvandi
Journal:  BMC Cancer       Date:  2008-11-11       Impact factor: 4.430

View more
  1 in total

1.  Associations Between Global Mental Health and Response to an App-Based Meditation Intervention in Myeloproliferative Neoplasm Patients.

Authors:  Megan E Puzia; Jennifer Huberty; Ryan Eckert; Linda Larkey; Ruben Mesa
Journal:  Integr Cancer Ther       Date:  2020 Jan-Dec       Impact factor: 3.279

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.